Back to search

Democritus University of Thrace (DUTH)

Ο ρόλος της υβριδικής ποζιτρονικής/αξονικής τομογραφίας (PET/CT) στη βελτιστοποίηση ακτινοθεραπευτικών πλάνων και στην αξιολόγηση της αποτελεσματικότητας της ακτινοθεραπείας σε ασθενείς με καρκίνο κεφαλής-τραχήλου και πνεύμονα

Abstract

dc:description

Modern radiotherapy relies heavily on accurate image guidance to achieve optimal target volume delineation and safe delivery of the prescribed therapeutic dose. Image fusion constitutes a fundamental component of radiotherapy planning, enabling the integration of anatomical and functional information within a unified geometric framework. Although computed tomography (CT) remains the reference imaging modality for dose calculation and anatomical definition, it exhibits inherent limitations in differentiating viable tumor tissue from normal, inflammatory, or atelectatic structures, as well as in the accurate detection of nodal disease. The incorporation of the nuclear imaging modality positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) through hybrid PET/CT imaging provides critical insights into cellular metabolism and tumor biological activity. The simultaneous acquisition of anatomical and functional data during the same imaging session and in the radiotherapy treatment position enables accurate image registration, reliable attenuation correction, and optimization of radiotherapy planning. In the present study, conducted at the University General Hospital of Alexandroupolis, the impact of18F-FDG PET/CT integration on radiotherapy planning was prospectively evaluated in patients with thoracic and head and neck malignancies. Patients with locally advanced non-small-cell lung cancer(NSCLC) and head and neck squamous cell carcinoma (HNSCC) treated with curative-intent radiotherapy, in combination with systemic therapy when indicated, were included. All patients underwent PET/CT-based radiotherapy simulation using standardized protocols for immobilization, imaging acquisition, target volume delineation, and dose prescription. For each patient, two sequential radiotherapy treatment plans were generated by the same radiation oncologist: one based solely on CT imaging and one incorporating fused PET/CT data. Planning target volumes (PTVs), dose–volume histograms, staging parameters, and the impact on overall treatment strategy were systematically analyzed and compared. The integration of PET/CT resulted in substantial modifications of both disease staging and radiotherapy planning in a significant proportion of patients. In the NSCLC cohort, PET/CT detected distant metastases in over 20% of cases, leading to revision of the overall therapeutic approach in asubset of patients and enabling radical radiotherapy in selected cases of oligometastatic disease. Furthermore, PET/CT-guided planning altered target volume delineation in the majority of patients, predominantly resulting in increased primary and nodal PTVs, suggesting potential underestimation of disease extent when CT-based planning alone is used. PET/CT also enabled reliable differentiation of malignant tissue within atelectatic regions and facilitated the inclusion or exclusion of lymph nodestations based on metabolic activity, thereby avoiding unnecessary irradiation. Similarly, in patients with HNSCC, PET/CT significantly affected TNM staging, particularly nodal staging, and revealed occult distant metastases, prompting reassessment of treatment strategy. PET/CT-guided delineation improved coverage of primary tumor volumes and identified metabolically active nodal regions not included in CT-based plans. These regions received subtherapeutic doses during CT-only planning, whereas PET/CT-based planning ensured adequate coverage and, in selected cases, dose escalation without a statistically significant increase in dose to organs at risk. In conclusion, 18F-FDG PET/CT constitutes a cornerstone of contemporary personalized radiotherapy, significantly enhancing target volume delineation accuracy, influencing staging and treatment decision-making, and reducing the risk of geographic miss. These findings support the routine integration of PET/CT into radiotherapy planning for lung and head-neck malignancies and warrant further investigation in larger cohorts with long-term follow-up to assess correlations with locoregional control and clinical outcomes.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Moulita, Antmir
  • Μουλίτα, Αντμίρ

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61005

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Moulita, Antmir; Μουλίτα, Αντμίρ. Ο ρόλος της υβριδικής ποζιτρονικής/αξονικής τομογραφίας (PET/CT) στη βελτιστοποίηση ακτινοθεραπευτικών πλάνων και στην αξιολόγηση της αποτελεσματικότητας της ακτινοθεραπείας σε ασθενείς με καρκίνο κεφαλής-τραχήλου και πνεύμονα. Democritus University of Thrace (DUTH), 2026. http://hdl.handle.net/10442/hedi/61005